Atlas Trials

Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer

Clinical trial NCT05533515 · COMPLETED

Trial details

NCT number
NCT05533515
Sponsor
Queen Mary University of London
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2022-02-08
Primary completion
2024-03-05
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.